Reaktion #319315

ord-b00380719f46424aa13e569df4cc1cb6

Lösungsmittel

Reaktionsbedingungen

Detaillierte Bedingungen
See reaction.notes.procedure_details.

Aufarbeitung

  1. 1
    SonstigeThen, a solution prepared
  2. 2
    workup.ADDITIONwas dropwise added
  3. 3
    workup.STIRRINGThe mixture was stirred for 5 minutes
  4. 4
    workup.STIRRINGThe mixture was stirred at room temperature for 10 minutes
  5. 5
    SonstigeThen, a solution prepared
  6. 6
    workup.ADDITIONwas gradually dropwise added
  7. 7
    workup.STIRRINGThe mixture was stirred overnight at room temperature
  8. 8
    FiltrationThen, after filtering
  9. 9
    Sonstigeprecipitated inorganic salt off, the reaction solution
  10. 10
    SonstigeThe reaction, solution
  11. 11
    Einengenwas concentrated under reduced pressure
  12. 12
    Sonstigea syrup thereby obtained
  13. 13
    Waschenwashed sequentially with 50 ml of water and 50 ml of a saturated sodium chloride aqueous solution
  14. 14
    Trocknendried over anhydrous magnesium sulfate
  15. 15
    FiltrationAfter filtering the inorganic salt off, the filtrate
  16. 16
    Einengenwas concentrated under reduced pressure
  17. 17
    Sonstigea syrup thereby obtained
  18. 18
    Sonstigewas purified by silica gel flash column chromatography (Kieselgel (E. Merck No. 9385), developer: hexane/ethyl acetate (10/1 ))
  19. 19
    workup.ADDITIONThe fraction containing the desired product
  20. 20
    Einengenwas concentrated
  21. 21
    Sonstigedried under reduced pressure

Vorschrift

68 mg of lithium chloride was suspended in 5 ml of dry tetrahydrofuran under an argon stream. Then, a solution prepared by dissolving 0.53 g of 2-diethylphosphono-4-(tetrahydropyran-2-yloxy)pentanoic acid in 1.0 ml of dry tetrahydrofuran, was dropwise added thereto under stirring. The mixture was stirred for 5 minutes, and 0.55 ml of a dry tetrahydrofuran solution of diazabicycloundecene (1/1) was gradually added thereto. The mixture was stirred at room temperature for 10 minutes. Then, a solution prepared by dissolving 385 mg of (4S,5S)-3-benzyloxycarbonyl-4-isobutyl-5-formyl-2,2-dimethyloxazolidine in 2.0 ml of dry tetrahydrofuran, was gradually dropwise added thereto. The mixture was stirred overnight at room temperature. Then, after filtering precipitated inorganic salt off, the reaction solution was neutralized with 1N hydrochloric acid. The reaction, solution was concentrated under reduced pressure, and a syrup thereby obtained was dissolved in 50 ml of benzene, then washed sequentially with 50 ml of water and 50 ml of a saturated sodium chloride aqueous solution and then dried over anhydrous magnesium sulfate. After filtering the inorganic salt off, the filtrate was concentrated under reduced pressure, and a syrup thereby obtained was purified by silica gel flash column chromatography (Kieselgel (E. Merck No. 9385), developer: hexane/ethyl acetate (10/1 )). The fraction containing the desired product was concentrated and dried under reduced pressure to obtain 454 mg of ethyl 3-[(4S,5S)-3-benzyloxycarbonyl-4-isobutyl-2,2-dimethyloxazolidin-5-yl]-2-[2-(2-tetrahydropyranyloxy)-propyl]-2-pentenoate as a colorless transparent syrup.

Quelle

DOI: 10.6084/m9.figshare.5104873.v1Patent: US04851387uspto-grants-1989_07